Company profile
Rhythm Pharmaceuticals, Inc.
Pipeline4 assets
- IMCIVREEsetmelanotide
- bivamelagonLB54640
- Preclinical small moleculesCongenital hyperinsulinism (CHI)
Latest news0 items
All newsNo recent headlines yet.
New company coverage will appear here as soon as it is picked up.